MBA-m1
MBA-m1 is a MLKL inhibitor. MBA-m1 inhibits necroptosis in Mlkl−/− NIH-3T3 cells. MBA-m1 ameliorates disease in MLKL-induced dermatitis and abdominal aortic aneurysm mouse model[1].
Product Specifications
CAS Number
[305866-70-0]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Mixed Lineage Kinase
Related Pathways
MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Purity
95.71
Smiles
ClC1=CC(NC2=CC(C)=NC3=C2C=C(OC)C=C3)=CC=C1OC4=CC5=C(C=CC=C5)C=C4
Molecular Formula
C27H21ClN2O2
Molecular Weight
440.92
Precautions
H302, H315, H319, H335
References & Citations
[1]Ros U, et al. MLKL activity requires a splicing-regulated, druggable intramolecular interaction. Mol Cell. 2025 Apr 17;85 (8) :1589-1605.e12.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
F4203-09-AP 200 µL
FIBG, CT (Fibrinogen gamma Chain, FGG, PRO2061) (AP) discontinued
Ask
View Details